Skip to content

Medical-device intelligence

PTD: Subcutaneous Implanted Apheresis Port

FDA product code PTD: Subcutaneous Implanted Apheresis Port. View classification details, related manufacturers, 510(k) clearances, and recall records.

FDA classification ↗

Classification details

Product code
PTD
FDA device name
Subcutaneous Implanted Apheresis Port
Device class
2
Regulation number
880.5965
Medical specialty
General Hospital
Review panel
HO

FDA definition

A subcutaneous implanted apheresis port is a prescription device intended for patient therapies requiring repeated access to the vascular system and long-term therapeutic apheresis
Explore general hospital records →
A product code groups records by FDA classification. It does not establish identical intended uses, commercial availability, or comparative device safety.

Record activity in this scope

3 clearance records and 0 recall records in the covered releases, across 2 source company names and 1 product codes. Dated history runs from Apr 17, 2017 to Aug 20, 2020.

Monthly counts through October 2026
Month510(k) decisionsRecall initiations
October 202500
November 202500
December 202500
January 202600
February 202600
March 202600
April 202600
May 202600
June 202600
July 202600
August 202600
September 202600
October 202600

Product codes represented

Code and FDA device nameClearancesRecalls
PTD · Subcutaneous Implanted Apheresis Port30

All-history totals use the covered releases; monthly counts stop at the last calendar month covered by both sources. Clearances use decision dates; recalls use initiation dates. 0 records lack the required date and are excluded from monthly counts. These are records, not product launches, market share, incidence rates, or comparative safety. Feed filters below do not change this overview.

Clearances and recall records

3 matching records
Device / recordCompany in FDA recordSourceSource date
TidalPort-AP Implantable Apheresis Vascular Access PortK192291 · PTDNorfolk Medical Products, Inc.510(k)Aug 20, 2020FDA decision date
PowerFlow Implantable Apheresis IV PortK191143 · PTDC.R. Bard, Inc.510(k)Aug 2, 2019FDA decision date
PowerFlow Apheresis I.V. PortK163001 · PTDC.R. Bard, Inc.510(k)Apr 17, 2017FDA decision date

Manufacturers in these records

Useful context

Device classifications

FDA dataset:

Last successful check: Nov 21, 2026

Source classifications may change.

510(k) clearances

FDA dataset:

Last successful check: Nov 21, 2026

FDA publishes this dataset monthly.

Recall records

FDA dataset:

Last successful check: Nov 21, 2026

FDA publishes this dataset weekly.

Keep this research moving.

Follow ten competitors and ten product codes. Get matching changes in your dashboard and a weekly brief, for $49/month.

Start a 14-day free trial ↗